What is the recommended dose of metronidazole (Flagyl) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Metronidazole Dosing for Pediatric Patients

The recommended dose of metronidazole for pediatric patients varies by indication, but generally ranges from 30-40 mg/kg/day divided every 8 hours for most infections, with a maximum of 500 mg per dose. 1

General Dosing Guidelines

  • For most pediatric infections requiring metronidazole, the standard dosing is 30-40 mg/kg/day divided into three doses (every 8 hours), with a maximum dose per administration of 500 mg 1
  • For children with amebiasis, the FDA-approved dosing is 35-50 mg/kg/24 hours, divided into three doses orally for 10 days 2
  • For anaerobic bacterial infections, the FDA-approved dosing is 7.5 mg/kg every six hours (approximately 500 mg for a 70 kg adult), with a maximum of 4 g per 24-hour period 2
  • The standard duration of therapy for most infections is 7-10 days, though some infections may require longer treatment 1, 2

Condition-Specific Dosing

Clostridium difficile Infection (CDI)

  • For initial episode or first recurrence of non-severe CDI: 7.5 mg/kg/dose three or four times daily for 10 days (maximum 500 mg per dose) 3, 4
  • For severe or fulminant CDI requiring IV therapy: 10 mg/kg/dose three times daily (maximum 500 mg per dose) 3, 4
  • For second or subsequent recurrences, oral vancomycin is recommended over metronidazole 3, 4

Intra-abdominal Infections

  • For intra-abdominal infections: 30-40 mg/kg/day divided every 8 hours as part of combination therapy 1
  • Metronidazole should be combined with other appropriate antibiotics for complicated intra-abdominal infections 1

Other Infections

  • For children below 12 years of age with anaerobic infections, dental infections, or protozoan infections: 20-30 mg/kg/day divided doses 5
  • For children 12 years and older: 200 mg to a maximum of 2000 mg per day 5

Special Considerations

  • For severe hepatic disease, doses should be reduced due to slower metabolism and potential accumulation of metronidazole and its metabolites 2
  • Once-daily dosing (30 mg/kg/dose) has been studied in pediatric appendicitis patients and achieved adequate target concentrations for Bacteroides fragilis with MIC ≤2 mcg/mL 6
  • In severely malnourished children, dosage reduction to 12 mg/kg/day (60% reduction from standard dose) may be warranted due to altered drug metabolism 7
  • Metronidazole dosing should be adjusted based on the severity of infection 1

Administration Routes

  • Metronidazole can be administered orally or intravenously, with parenteral administration likely resulting in higher bioavailability 3, 1
  • For severe infections, initial intravenous therapy is often recommended before transitioning to oral therapy 2, 8

Monitoring and Safety

  • No test doses are necessary when starting low-dose metronidazole for inflammatory skin disease 3
  • Monitoring of serum levels may be necessary in elderly patients due to altered pharmacokinetics 2
  • The most common side effects are gastrointestinal (nausea, vomiting, bitter taste) and are typically mild 9

References

Guideline

Pediatric Metronidazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metronidazole Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A new dosing regimen for metronidazole in malnourished children.

Scandinavian journal of infectious diseases, 1993

Research

Treatment of anaerobic infections in children with metronidazole.

Developmental pharmacology and therapeutics, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.